.
GWAS implicated several VPS10P domain receptors in cardiovascular and metabolic diseases.
SORLA promotes atherosclerosis by facilitation of smooth muscle cell migration in the vessel wall.
SORLA is also a clearance receptor for apoA-V, regulating lipolysis of triglyceride-rich lipoproteins.
Sortilin controls hepatic lipoprotein metabolism and PCSK9 action.
SORCS1 is a risk factor for diabetes modulating insulin secretion from pancreatic islets.